Yorktown Management & Research CO Inc Veracyte, Inc. Transaction History
Yorktown Management & Research CO Inc
- $86.9 Million
- Q1 2025
A detailed history of Yorktown Management & Research CO Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Yorktown Management & Research CO Inc holds 8,900 shares of VCYT stock, worth $278,748. This represents 0.3% of its overall portfolio holdings.
Number of Shares
8,900Holding current value
$278,748% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
329Shares Held
76.9MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.26MShares$259 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$244 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$207 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$123 Million1.26% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$96.5 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.24B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...